Michael Perry
Director/Board Member at ARROWHEAD PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 30/04/2024
Network origin in Michael Perry first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
41
| Subsidiary | Pharmaceuticals: Major | 41 |
| Public Company | Biotechnology | 33 | |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.
31
| Extinct | Biotechnology | 31 |
| Public Company | Pharmaceuticals: Major | 22 | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA.
20
| Subsidiary | Biotechnology | 20 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.
19
| Subsidiary | Investment Managers | 19 |
18
| Public Company | Pharmaceuticals: Major | 18 |
| Public Company | Medical Specialties | 15 | |
| Public Company | Biotechnology | 13 | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.
9
| Private Company | Investment Managers | 9 |
Sandoz Pharmaceuticals Corp.
8
| Subsidiary | 8 | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD.
8
| Subsidiary | Biotechnology | 8 |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams.
8
| Subsidiary | Biotechnology | 8 |
| Public Company | Biotechnology | 7 | |
VIA Pharmaceuticals, Inc. /Old/
 VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology VIA Pharmaceuticals, Inc. develops pharmaceutical products. It focuses on small-molecule drugs that target inflammation in the blood vessel wall as an innovative approach to treatment of cardiovascular disease. The company's strategy is to identify, acquire and develop compounds that intervene in the process of vascular inflammation, to reduce the incidence of major cardiovascular events and provide a significant clinical benefit to patients. It was founded in June, 2004 by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given. VIA is headquartered in San Francisco, CA.
6
| Extinct | Pharmaceuticals: Major | 6 |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.
6
| Extinct | Medical/Nursing Services | 6 |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London.
6
| Private Company | Investment Managers | 6 |
Pharsight Corp.
 Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets.
4
| Extinct | Packaged Software | 4 |
7 Hills Pharma LLC
 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation.
3
| Private Company | Pharmaceuticals: Major | 3 |
Extropy Pharmaceuticals, Inc.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Perry via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO President General Counsel President Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO President President | |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Biotechnology | Chairman Chief Executive Officer Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Rothschild & Co. Asset Management US, Inc.
 Rothschild & Co. Asset Management US, Inc. Investment ManagersFinance Rothschild & Co. Asset Management US, Inc. (R&Co) is an asset management firm headquartered in Stamford, Connecticut. The firm was founded in 1962 and formerly known as Rothschild Asset Management, Inc. They are a wholly-owned subsidiary of Great Lakes Advisors LLC and their ultimate parent is Wintrust Financial Corp. (NASDAQ: WTFC). R&Co provides investment advisory and sub-advisory services on a discretionary basis to a broad range of clients. They also provide non-discretionary investment advice to various wrap model delivery managed account programs. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Consultant / Advisor Corporate Officer/Principal Corporate Officer/Principal | |
| SEMBIOSYS GENETICS I | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Biotechnology | Chairman Chief Executive Officer Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Investor Relations Contact | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director of Finance/CFO | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree Graduate Degree Masters Business Admin | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Bar-Ilan University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Undergraduate Degree | |
Visirna Therapeutics, Inc.
 Visirna Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Visirna Therapeutics, Inc. manufactures and commercializes RNAi-based investigational cardiometabolic medicines. The company is based in Shanghai, China. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| Wellesley College | College/University | Undergraduate Degree Undergraduate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biocontrol Ltd. (United Kingdom)
 Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| Texas A&M University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Summatix Pty Ltd.
 Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member Director/Board Member | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Unidym, Inc.
 Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Electronic Production Equipment | Director/Board Member Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
| PHILIPS NV | Medical Specialties | Director/Board Member Chief Executive Officer | |
| PYC THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Chairman Chief Executive Officer | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Chairman Investor Relations Contact |
Statistics
International
| United States | 36 |
| Israel | 5 |
| United Kingdom | 4 |
| Australia | 3 |
| Switzerland | 3 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 14 |
| Finance | 3 |
| Commercial Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 653 |
| Corporate Officer/Principal | 224 |
| Independent Dir/Board Member | 169 |
| Chief Executive Officer | 114 |
| Chairman | 106 |
Most connected contacts
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Michael Barrett | 49 |
| Douglass Given | 35 |
| Nicholas Simon | 33 |
| Hadar Resnekov-Ron | 30 |
| Nicole Vitullo | 28 |
| Hong Bo Lu | 28 |
| David Epstein | 28 |
| Lionel Carnot | 27 |
| Dennis Purcell | 26 |
| Roger Kornberg | 24 |
| Adeoye Olukotun | 24 |
| Frans van Houten | 23 |
| Boaz Lifschitz | 23 |
| Stephen Wills | 22 |
- Stock Market
- Insiders
- Michael Perry
- Company connections
